Alnylam Pharmaceuticals, Inc. (ALNY)

USD 237.92

(-3.51%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 3.82 Billion 3.54 Billion 3.64 Billion 3.4 Billion 2.39 Billion 1.57 Billion
Total Current Assets 2.98 Billion 2.69 Billion 2.86 Billion 2.15 Billion 1.73 Billion 1.2 Billion
Cash And Short Term Investments 2.43 Billion 2.19 Billion 2.43 Billion 1.87 Billion 1.53 Billion 1.08 Billion
Cash and Cash Equivalents 812.68 Million 866.39 Million 819.97 Million 496.58 Million 547.17 Million 420.14 Million
Short Term Investments 1.62 Billion 1.32 Billion 1.61 Billion 1.37 Billion 988.98 Million 664 Million
Net Receivables 327.78 Million 237.96 Million 198.57 Million 102.41 Million 43.01 Million 18.76 Million
Inventory 89.14 Million 128.96 Million 122.7 Million 92.3 Million 56.34 Million 24.06 Million
Other Current Assets 126.38 Million 132.91 Million 111.94 Million 90.71 Million 98.41 Million 83.54 Million
Total Non-Current Assets 847.18 Million 854.11 Million 774.52 Million 1.24 Billion 661.2 Million 365.48 Million
Net PPE 725.78 Million 738.63 Million 733.63 Million 706.51 Million 646.37 Million 320.65 Million
Good Will And Intangible Assets 697.78 Million 264.56 Million - - - -
Good Will - - - - - -
Intangible Assets 697.78 Million 264.56 Million - - - -
Long-Term Investments 51.58 Million -2.55 Billion 40.89 Million 40.72 Million 14.82 Million 44.82 Million
Tax Assets 2.89 Billion 2.29 Billion - - - -
Other Non Current Assets -3.52 Billion 115.48 Million - 500 Million - -
Other Assets - - - - - -
Total Liabilities 4.05 Billion 3.7 Billion 3.05 Billion 2.39 Billion 956.44 Million 272.83 Million
Total Current Liabilities 967.78 Million 767.91 Million 1.19 Billion 1.12 Billion 956.44 Million 242.83 Million
Account Payables 55.51 Million 98.09 Million 73.42 Million 51.96 Million 49.88 Million 59.7 Million
Tax Payables - - - - - -
Short Term Debt 96.5 Million 41.96 Million 321.89 Million 329.91 Million 303.82 Million 62.88 Million
Deferred Revenue 102.75 Million 42.1 Million 301.84 Million 352.3 Million 396.2 Million 3.95 Million
Other Current Liabilities 713.01 Million 585.74 Million 494.13 Million 393.81 Million 206.53 Million 116.29 Million
Total Non Current Liabilities 3.08 Billion 2.93 Billion 1.86 Billion 1.26 Billion 603.84 Million 30 Million
Long-Term Debt 2.34 Billion 1.27 Billion 675.69 Million 191.27 Million 276.13 Million 30 Million
Deferred Revenue Non Current 188.17 Million 193.79 Million 152.36 Million 225.09 Million 318.38 Million 458 Thousand
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 308.43 Million 1.46 Billion 1.18 Billion 1.07 Billion -594.51 Million 4.96 Million
Other Liabilities - - - - -603.84 Million -
Total Equity -220.64 Million -158.22 Million 588.2 Million 1.01 Billion 1.43 Billion 1.3 Billion
Stock Holders Equity -220.64 Million -158.22 Million 588.2 Million 1.01 Billion 1.43 Billion 1.3 Billion
Common Stock 1.25 Million 1.24 Million 1.2 Million 1.16 Million 1.12 Million 1.01 Million
Retained Earnings -7 Billion -6.56 Billion -5.43 Billion -4.58 Billion -3.72 Billion -2.84 Billion
Accumulated other comprehensive income -23.37 Million -44.65 Million -33.25 Million -43.62 Million -36.51 Million -33.21 Million
Common Stock Equity -220.64 Million -158.22 Million 588.2 Million 1.01 Billion 1.43 Billion 1.3 Billion
Capital Lease Obligation 243.1 Million 303.3 Million 321.89 Million 329.91 Million 303.82 Million -
Total Investments 1.67 Billion 1.32 Billion 1.61 Billion 1.37 Billion 1 Billion 664 Million
Total Debt 2.68 Billion 1.32 Billion 997.59 Million 521.18 Million 303.82 Million 30 Million
Net Debt 1.86 Billion 453.85 Million 177.61 Million 24.6 Million -243.35 Million -390.14 Million

Balance Sheet Charts